FRA:NXU - Deutsche Boerse Ag - DE0005220909 - Common Stock - Currency: EUR
FRA:NXU (5/23/2025, 4:32:20 PM)
74
+1.7 (+2.35%)
The current stock price of NXU.DE is 74 EUR. In the past month the price increased by 3.88%. In the past year, price increased by 22.75%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
COP.DE | COMPUGROUP MEDICAL SE & CO K | 42.5 | 1.19B | ||
EQS.PA | EQUASENS | 21 | 761.53M | ||
CONTX.OL | CONTEXTVISION AB | 14.21 | 373.70M | ||
GPI.MI | GPI SPA | 2.9 | 300.66M | ||
CGM.PA | CEGEDIM SA | N/A | 161.09M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 139.65M | ||
AJ91.DE | DOCCHECK AG | 25 | 60.84M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 42.94M | ||
ALINS.PA | INTRASENSE SAS | N/A | 14.66M | ||
MLLAB.PA | MEDIA LAB SPA | N/A | 5.21M |
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,774 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
NEXUS AG
Irmastrasse 1
Donaueschingen BADEN-WUERTTEMBERG DE
Employees: 1909
Phone: 49771229600
The current stock price of NXU.DE is 74 EUR. The price increased by 2.35% in the last trading session.
The exchange symbol of NEXUS AG is NXU and it is listed on the Deutsche Boerse Ag exchange.
NXU.DE stock is listed on the Deutsche Boerse Ag exchange.
9 analysts have analysed NXU.DE and the average price target is 70.76 EUR. This implies a price decrease of -4.37% is expected in the next year compared to the current price of 74. Check the NEXUS AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NEXUS AG (NXU.DE) has a market capitalization of 1.28B EUR. This makes NXU.DE a Small Cap stock.
NEXUS AG (NXU.DE) currently has 1909 employees.
NEXUS AG (NXU.DE) has a support level at 71.15 and a resistance level at 72.31. Check the full technical report for a detailed analysis of NXU.DE support and resistance levels.
The Revenue of NEXUS AG (NXU.DE) is expected to grow by 9.04% in the next year. Check the estimates tab for more information on the NXU.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NEXUS AG (NXU.DE) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.22. Check the full fundamental report for a detailed analysis of NXU.DE dividend history, reliability and sustainability.
NEXUS AG (NXU.DE) will report earnings on 2025-08-11.
The PE ratio for NEXUS AG (NXU.DE) is 41.34. This is based on the reported non-GAAP earnings per share of 1.79 and the current share price of 74 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NXU.DE.
ChartMill assigns a technical rating of 8 / 10 to NXU.DE. When comparing the yearly performance of all stocks, NXU.DE is one of the better performing stocks in the market, outperforming 86.16% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE. NXU.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months NXU.DE reported a non-GAAP Earnings per Share(EPS) of 1.79. The EPS increased by 28.21% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.79% | ||
ROA | 7.04% | ||
ROE | 11.04% | ||
Debt/Equity | 0.06 |
ChartMill assigns a Buy % Consensus number of 49% to NXU.DE. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 14.6% and a revenue growth 9.04% for NXU.DE